Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
Clinical trial NCT03021057 · UNKNOWN
Trial details
- NCT number
- NCT03021057
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2020-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.